ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2021
TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma.
Xiao-Ming Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papercites it